TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile November 30, 2012